Pharmacokinetics and Safety of Intravenous Candidate Biosimilar CT-P47 and Reference Tocilizumab: A Randomized, Double-Blind, Phase 1 Study
Journal of clinical pharmacology(2024)
Key words
biosimilar,CT-P47,immunogenicity,pharmacokinetics,safety,tocilizumab
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined